% Net Profit 1.3% 6.7% EBITDA (MB) 9.0 20.8 -56.9% EBITDA (%) 5.1% 11.7% Earnings per share (Baht) - 0.02 -100.0% Remark : EBITDA = Profit before finance costs, income tax, Depreciation and Amortization
volume. Gross Profit Margin Gross profit margin is equal to 32.30% in 2Q17, which slightly declined from the same period of last year which was 33.83%. The main cause stemmed from the duplicated costs of
% 10.1% EBITDA (MB) 21.9 37.0 -40.8% EBITDA (%) 9.7% 18.0% Earnings per share (Baht) 0.02 0.04 -50.0% Remark : EBITDA = Profit before finance costs, income tax, Depreciation and Amortization Statement of
% 2.2% EBITDA (MB) 27.8 14.9 86.3% EBITDA (%) 14.6% 6.2% Earnings per share (Baht) 0.03 0.01 200.0% Remark : EBITDA = Profit before finance costs, income tax, Depreciation and Amortization Statement of
Financial expenses 1.76 0.30% 1.60 0.33% 0.16 9.98 Share of losses from associates 0.17 0.03% 0 0% 0.17 100 Income tax 8.12 1.37% 6.92 1.42% 1.21 17.44 Net profit 21.14 3.58% 37.03 7.61% (15.89) (42.92
clarifies the performance as follows: During the first quarter of 2020, the Company had the total revenue and share of profit and net profit of THB 1,277.8 mm and THB 99.3 mm, respectively. If excluding FX
Exchange of Thailand with a view to share the information with general investors. The key indicators and changes regarding to the operating performance and financial status are as follows: 1. Operating
) (49.14) Per Share (Baht) Net profit per share 0.02 0.05 (0.02) Unit : THB'000 NO. AC. 003/2017 11 August 2017 Subject: Clarification of changes in operating performance of more than 20% To: The President
hrs. has approved investment in N Hospital Co.,Ltd which engaging in healthcare business, hospital, pharmaceuticals and medical equipment. Share of registered capital total baht 765,000,000 and Paid-up
companies in 2017 was 9,612.85 million THB, decreasing 4,988.67 million THB or 34.17% from that in 2016. More than 90% of the main income was achieved from sale which decreased from 13,855.41 million THB in